Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)—A randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness

This publication has 49 references indexed in Scilit:

• Effect of the HMG-CoA Reductase Inhibitors on Blood Pressure in Patients With Essential Hypertension and Primary Hypercholesterolemia
  Hypertension, 1999
• Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias
  QJM: An International Journal of Medicine, 1999
• Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I
  The American Journal of Cardiology, 1999
• Antiatherothrombotic Properties of Statins
  JAMA, 1998
• Statin trials and goals of cholesterol-lowering therapy.
  Circulation, 1998
• Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
  Circulation, 1998
• Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial
  Circulation, 1998
• Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
  The American Journal of Cardiology, 1998
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?
  JAMA, 1986